FDA Inspection 1171416 — Central Iowa Health System
The FDA completed an inspection of Central Iowa Health System on May 12, 2022 in Des Moines, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 12, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Des Moines, IA (United States)